CLEVELAND — The Center for Disease Control and Prevention’s National Center for Immunization and Respiratory Diseases awarded University Hospitals a grant to support its assignment as a study site in the United States Flu Vaccine Effectiveness network.
What You Need To Know
- Study sites in the U.S. Flu VE network give estimates for the clinical effectiveness of licensed vaccines
- The CDC approved $12.5 million in grant money, with the potential for an $8 million increase, for a five-year cooperative agreement with University Hospitals
- University Hospitals will complete this research among patients seeking health care for acute respiratory illness and related symptoms
According to a University Hospitals press release, study sites in the U.S. Flu VE network give estimates for the clinical effectiveness of licensed vaccines.
The U.S. Flu VE network examines how vaccine effectiveness changes based on person, age group and influenza type in order to gain an understanding of how vaccines work in a real world setting.
The CDC approved $12.5 million in grant money, with the potential for an $8 million increase, for a five-year cooperative agreement with University Hospitals. This agreement will begin in Sept. 2022 and end in Sept. 2027.
“University Hospitals is honored to be chosen by the CDC to participate in this important study and our selection speaks to the strong reputation of UH in the area of academic research,” said Dr. Elie Saade, Principal Investigator of the study and Director of Infection Control at University Hospitals.
University Hospitals is one of seven U.S. institutions, and the only site in Ohio, that will identify laboratory-confirmed cases of acute respiratory illness due to influenza, COVID-19 and other viruses.
University Hospitals will complete this research among patients seeking health care for acute respiratory illness and related symptoms. Researchers will inspect the body’s response to the infection or vaccine.
“The mission of University Hospitals is to heal, to teach and to discover,” said Dr. Robert Salata, Program Director, Roe Green Center for Travel Medicine and Global Health; Physician-in-Chief, and STERIS Chair of Excellence in Medicine, University Hospitals. “As part of this network, we can accomplish all three, discovering vital information that will be used to keep people in Northeast Ohio and across the country healthy.
University Hospitals will work with VA Northeast Ohio Healthcare System and Case Western Reserve University.
